心臓補綴デバイス市場レポート：製品タイプ、エンドユーザー、地域別、2024年～2032年

世界の心臓補綴デバイスの市場規模は2023年に67億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて6.8%の成長率（CAGR）を示し、2032年までに123億米ドルに達すると予測しています。小型ペースメーカーや無縫合弁置換術の市場開拓、低侵襲（MI）手技への傾斜の高まり、大衆の間での心血管障害の有病率の上昇が、市場を推進している主な要因の一部です。

心臓補綴デバイス市とは、心臓の正常な機能を代替または補助するように設計された人工装置またはインプラントを指します。心不全、弁障害、先天性心疾患など、さまざまな心臓疾患の治療に使用されます。人工心臓弁と機械的循環補助装置の2種類に大別されます。人工心臓弁は、損傷したり病気になったりした心臓弁の代わりに使用され、心臓を通る正常な血流を回復させる。一方、機械的循環補助装置は、心臓のポンプ機能を補助または代替するために使用され、移植への橋渡しとして、あるいは心臓移植に不適格な患者の長期的な解決策として用いられることが多いです。また、生体適合性のある材料で製造され、心臓の構造と機能を再現するように綿密に設計されているため、患者の心臓機能と生活の質を向上させることができます。

この業界を牽引しているのは、世界人口の高齢化です。人口の高齢化が進むにつれて、心血管疾患の発生率が増加し、心臓補綴デバイスの需要が高まっています。さらに、医療技術や手術技術の継続的な進歩により、心血管疾患患者の生存率が向上しているため、人工心臓の患者数が増加しています。これとともに、心血管系の健康に対する意識の高まりと、大衆の間で治療オプションが利用可能になったことが、製品需要に拍車をかけています。また、患者は生活の質の向上と生存期間の延長のために、心臓補綴デバイス市の使用を含むタイムリーな介入を求めており、これは市場にプラスの影響を与えています。ヘルスケア分野における継続的な発展や、主要企業による広範な研究開発（R&D）活動など、その他の要因も市場にプラスの影響を与えています。

心臓補綴デバイス市場動向/促進要因：

心血管疾患の有病率と認知度の向上

冠動脈疾患、心不全、心臓弁膜症などの心血管疾患は、世界中で罹患率と死亡率の大きな要因となっています。さらに、心臓病、予防対策、治療オプションの利用可能性に関する意識の高まりは、心血管疾患の早期発見と診断につながっています。心エコー検査や心臓MRIのような高度な画像診断技術を含む診断能力の向上は、正確な診断と心臓補綴デバイス市の恩恵を受ける可能性のある患者の特定を容易にしています。国民の意識と多くの疾患の有病率の上昇が相まって、製品需要が増加しています。より多くの患者がより早い段階でCVDと診断されるようになり、心臓補綴を含む介入から恩恵を受ける可能性のある患者層が拡大しています。

有利な償還政策の実施

診療報酬は心臓補綴デバイス市の導入において重要な役割を果たします。政府のヘルスケアシステムや民間の保険プロバイダーが提供する好意的な償還政策は、医療提供者にこれらの機器や処置を患者に提供するインセンティブを与えます。これにより、患者の経済的障壁が軽減され、心臓補綴デバイス市の使用が促進されるため、市場成長に資する環境が整う。さらに、疾病負担の増加や医療技術の進歩により、世界中でヘルスケア支出が増加しています。このような医療費の増加は、心臓補綴デバイスの手頃な価格と入手しやすさに貢献しており、必要とする患者がより広く利用できるようになっています。これに加えて、市場プレイヤーはパートナーシップ、コラボレーション、販売網を確立しつつあり、これがもう一つの成長促進要因として作用しています。

心臓手術の技術および機器における絶え間ない技術革新

低侵襲手術、ロボット支援手術、経カテーテルインターベンションなど、心臓外科技術における絶え間ない進歩は、さまざまな心臓疾患の治療範囲を拡大してきました。このような進歩により、心臓弁、補助人工心臓（VAD）、ペースメーカーなど、これらの手技で重要な役割を果たす製品の利用が増加しています。技術の急速な進歩は、心臓補綴デバイスのデザインと機能性に革命をもたらしました。例えば、経カテーテル心臓弁の開発により、侵襲の少ない弁置換術が可能になり、患者の外傷や回復時間が短縮されました。さらに、ペースメーカーや植え込み型除細動器（ICD）にワイヤレス接続、遠隔モニタリング機能、高度なセンサーが統合されたことで、患者のケアと転帰が改善され、市場の見通しは明るいです。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の心臓補綴デバイス市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品タイプ別

• バルブ
  • 市場動向
  • 主な種類
    • 機械弁
    • 組織弁
    • ステント式生体弁
    • ステントレス生体弁
    • 経カテーテル弁
  • 市場予測
• ペースメーカー
  • 市場動向
  • 市場予測
• 埋め込み型ペースメーカー
  • 市場動向
  • 主な種類
    • 単室電池ペースメーカー
    • デュアルチャンバーバッテリーペースメーカー
    • 三室電池ペースメーカー
  • 市場予測
• 体外ペースメーカー
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第7章 市場内訳：エンドユーザー別

• 病院、診療所、心臓センター
  • 市場動向
  • 市場予測
• 外来手術センター
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第8章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第9章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第12章 価格分析

第13章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abbott Laboratories
  • Biotronik
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology Co. Ltd.
  • Medtronic Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Siemens Healthcare GmbH
  • Sorin Group
  • St. Jude Medical Inc.

List of Figures

• Figure 1: Global: Cardiac Prosthetic Devices Market: Major Drivers and Challenges
• Figure 2: Global: Cardiac Prosthetic Devices Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Cardiac Prosthetic Devices Market: Breakup by Product Type (in %), 2023
• Figure 4: Global: Cardiac Prosthetic Devices Market: Breakup by End-User (in %), 2023
• Figure 5: Global: Cardiac Prosthetic Devices Market: Breakup by Region (in %), 2023
• Figure 6: Global: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 7: Global: Cardiac Prosthetic Devices (Valves) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 8: Global: Cardiac Prosthetic Devices (Valves) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 9: Global: Cardiac Prosthetic Devices (Pacemakers) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 10: Global: Cardiac Prosthetic Devices (Pacemakers) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 11: Global: Cardiac Prosthetic Devices (Implantable Pacemakers) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 12: Global: Cardiac Prosthetic Devices (Implantable Pacemakers) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 13: Global: Cardiac Prosthetic Devices (External Pacemakers) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 14: Global: Cardiac Prosthetic Devices (External Pacemakers) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 15: Global: Cardiac Prosthetic Devices (Others) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 16: Global: Cardiac Prosthetic Devices (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 17: Global: Cardiac Prosthetic Devices (Hospitals, Clinics and Cardiac Centers) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 18: Global: Cardiac Prosthetic Devices (Hospitals, Clinics and Cardiac Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 19: Global: Cardiac Prosthetic Devices (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 20: Global: Cardiac Prosthetic Devices (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 21: Global: Cardiac Prosthetic Devices (Others) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 22: Global: Cardiac Prosthetic Devices (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 23: North America: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 24: North America: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 25: United States: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 26: United States: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 27: Canada: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 28: Canada: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 29: Asia Pacific: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 30: Asia Pacific: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 31: China: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 32: China: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 33: Japan: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 34: Japan: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 35: India: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 36: India: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 37: South Korea: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 38: South Korea: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 39: Australia: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 40: Australia: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 41: Indonesia: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 42: Indonesia: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 43: Others: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 44: Others: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 45: Europe: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 46: Europe: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 47: Germany: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 48: Germany: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 49: France: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 50: France: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 51: United Kingdom: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 52: United Kingdom: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 53: Italy: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 54: Italy: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 55: Spain: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 56: Spain: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 57: Russia: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 58: Russia: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 59: Others: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 60: Others: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 61: Latin America: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 62: Latin America: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 63: Brazil: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 64: Brazil: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 65: Mexico: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 66: Mexico: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 67: Others: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 68: Others: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 69: Middle East and Africa: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 70: Middle East and Africa: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 71: Global: Cardiac Prosthetic Devices Industry: SWOT Analysis
• Figure 72: Global: Cardiac Prosthetic Devices Industry: Value Chain Analysis
• Figure 73: Global: Cardiac Prosthetic Devices Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Cardiac Prosthetic Devices Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Cardiac Prosthetic Devices Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
• Table 3: Global: Cardiac Prosthetic Devices Market Forecast: Breakup by End-User (in Million US$), 2024-2032
• Table 4: Global: Cardiac Prosthetic Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 5: Global: Cardiac Prosthetic Devices Market: Competitive Structure
• Table 6: Global: Cardiac Prosthetic Devices Market: Key Players

The global cardiac prosthetic devices market size reached US$ 6.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032. The development of compact pacemakers and suture-less valve replacements, the growing inclination toward minimally invasive (MI) procedures, and the rising prevalence of cardiovascular disorders among the masses are some of the major factors propelling the market.

Cardiac prosthetic devices refer to artificial devices or implants designed to replace or assist the normal functioning of the heart. They are used in the treatment of various heart conditions, such as heart failure, valve disorders, or congenital heart defects. They can be broadly categorized into two types, artificial heart valves and mechanical circulatory support devices. Artificial heart valves are used to replace damaged or diseased heart valves, restoring normal blood flow through the heart. On the other hand, mechanical circulatory support devices are used to assist or replace the pumping function of the heart, often employed as a bridge to transplantation or as a long-term solution for patients ineligible for heart transplantation. Additionally, they are manufactured of biocompatible materials and are meticulously designed to replicate the structure and function of the heart, thereby improving the patient's cardiac function and quality of life.

The industry is driven by the aging global population. As the population continues to age, the incidence of cardiovascular diseases increases, leading to a higher demand for cardiac prosthetic devices. Additionally, continual advancements in medical technology and surgical techniques have improved the survival rates of patients with cardiovascular diseases, this is creating a larger patient pool for these devices. Along with this, the increasing awareness about cardiovascular health and the availability of treatment options among the masses is fueling the product demand. Also, patients are seeking timely interventions, including the use of cardiac prosthetic devices, to improve their quality of life and prolong survival, which is positively influencing the market. Other factors, including continual developments in the healthcare sector and extensive research and development (R&D) activities conducted by key players, are also positively influencing the market.

Cardiac Prosthetic Devices Market Trends/Drivers:

Increasing Prevalence of Cardiovascular Diseases and their Awareness

Cardiovascular diseases, including coronary artery disease, heart failure, and valvular heart diseases, are significant contributors to morbidity and mortality across the globe. Additionally, the increasing awareness about heart diseases, preventive measures, and the availability of treatment options has led to earlier detection and diagnosis of cardiovascular conditions. Improved diagnostic capabilities, including advanced imaging techniques, such as echocardiography and cardiac MRI, facilitate accurate diagnosis and identification of patients who may benefit from cardiac prosthetic devices. The combination of public awareness and the rising prevalence of numerous diseases has led to an increasing product demand. As more individuals are diagnosed with CVDs at an earlier stage, there is a growing pool of patients who could benefit from interventions involving cardiac prosthetics.

The Implementation of Favorable Reimbursement Policies

Reimbursement plays a vital role in the adoption of cardiac prosthetic devices. Favorable reimbursement policies offered by government healthcare systems and private insurance providers incentivize healthcare providers to offer these devices and procedures to their patients. This creates a conducive environment for market growth, as it reduces financial barriers for patients and promotes the use of cardiac prosthetic devices. In addition, the rising disease burden, and advances in medical technology are increasing healthcare expenditure across the globe. This higher healthcare spending is contributing to the affordability and accessibility of cardiac prosthetic devices, making them more widely available to patients in need. Besides this, market players are establishing partnerships, collaborations, and distribution networks, which are acting as another growth-inducing factor.

Continual Technological Innovations in Cardiac Surgery Techniques and Devices

Continuous advancements in cardiac surgical techniques, such as minimally invasive procedures, robotic-assisted surgeries, and transcatheter interventions, have expanded the scope of treating various cardiac conditions. These advancements have increased product utilization, including heart valves, ventricular assist devices (VADs), and pacemakers, as they play a crucial role in these procedures. Rapid advancements in technology have revolutionized the design and functionality of cardiac prosthetic devices. For instance, the development of transcatheter heart valves has enabled less invasive valve replacement procedures, reducing patient trauma and recovery time. Additionally, the integration of wireless connectivity, remote monitoring capabilities, and advanced sensors in pacemakers and implantable cardioverter-defibrillators (ICDs) has improved patient care and outcomes, creating a positive market outlook.

Cardiac Prosthetic Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cardiac prosthetic devices report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type and end-user.

Breakup by Product Type:

Valves

Mechanical Valve

Tissue Valve

Stented Tissue Valve

Stentless Tissue Valve

Transcatheter Valve

Pacemakers

Implantable Pacemakers

Single-Chamber Battery Pacemaker

Dual-Chamber Battery Pacemaker

Triple-Chamber Battery Pacemaker

External Pacemakers

Others

Valves dominate the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes valves (mechanical valve, tissue valve, stented tissue valve, stentless tissue valve, and transcatheter valve), pacemakers, implantable pacemakers (single-chamber battery pacemaker, dual-chamber battery pacemaker, and triple-chamber battery pacemaker), external pacemakers, and others. According to the report, valves represented the largest segment.

Continual technological advancements in valve design and materials have improved the durability, functionality, and overall performance of devices, leading to greater acceptance and adoption. Additionally, the increasing focus on minimally invasive procedures and the development of transcatheter heart valve replacement techniques are positively influencing the demand for valve products.

Additionally, continuous advancements in medical technology have led to the development of innovative pacemaker devices with improved features and functionalities, including wireless connectivity and remote monitoring capabilities, which further drive market growth. Moreover, the rising prevalence of lifestyle-related diseases, such as obesity and diabetes, which are risk factors for heart ailments, is fueling the demand for pacemakers across the globe.

Breakup by End-User:

Hospitals, Clinics and Cardiac Centers

Ambulatory Surgical Centers

Others

Hospitals, clinics and cardiac centers hold the largest share in the market

A detailed breakup and analysis of the market based on the end-user has also been provided in the report. This includes hospitals, clinics and cardiac centers, ambulatory surgical centers, and others. According to the report, hospitals, clinics, and cardiac centers accounted for the largest market share.

The increasing usage of these devices in hospitals, clinics, and cardiac centers can be attributed to the continual advancements in medical technology and surgical techniques. The continuous development of innovative devices, such as artificial heart valves and implantable pacemakers, enables healthcare providers to offer improved treatment options to patients. Furthermore, various government initiatives and healthcare reforms aimed at enhancing cardiovascular care and improving patient outcomes also serve as major market drivers for the end-users in the industry.

On the contrary, ambulatory surgical centers (ASCs) as end-users in the cardiac offer numerous advantages, such as cost-effectiveness, convenience, and reduced hospital stays, which are particularly appealing to patients seeking cardiac procedures. These centers provide a suitable environment for minimally invasive surgeries and outpatient treatments, aligning with the growing trend towards value-based healthcare. Additionally, advancements in technology have made it feasible to perform complex cardiac procedures in ASCs, further fueling the market demand in this segment over the forecast period.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest the cardiac prosthetic devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The market in North America is driven by the increasing prevalence of cardiovascular diseases and the growing aging population. As heart-related conditions become more common, the need for devices such as heart valves, pacemakers, and implantable defibrillators is growing. Additionally, the healthcare system across the region focuses on quality healthcare delivery and reimbursement support for medical devices also plays a significant role in the growth of the market. Moreover, research and development efforts aimed at developing innovative and minimally invasive prosthetic devices are significantly supporting the market.

On the contrary, Asia Pacific is estimated to expand further in this domain in the coming years due to the aging population and changing lifestyles. In confluence with this, advancements in healthcare infrastructure and the rising disposable income in several countries within the Asia Pacific region have improved access to medical treatments and increased affordability. Furthermore, ongoing technological advancements and innovations in the field are driving the market in Asia Pacific.

Competitive Landscape:

The market is experiencing significant growth due to the continual advancements in medical technology and surgical procedures leading to the development of innovative and more efficient devices. Additionally, the integration of digital health technologies is creating opportunities for companies to offer remote monitoring solutions and personalized healthcare services, enhancing patient outcomes and increasing the overall value proposition of their products. Also, numerous companies are developing tailored solutions to address specific patient needs, this is gaining prominence across the globe. Moreover, the development of 3D printing technology has further facilitated the production of patient-specific devices, allowing for better fit and improved functionality. Additionally, top companies are investing in research and development to create customizable solutions and collaborate with healthcare professionals to understand patient requirements, which is influencing the market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Biotronik

Boston Scientific Corporation

Edwards Lifesciences Corporation

Lepu Medical Technology Co. Ltd.

Medtronic Inc.

Meril Life Sciences Pvt. Ltd.

Siemens Healthcare GmbH

Sorin Group

St. Jude Medical Inc.

Recent Developments:

In September 2021, Abbott Laboratories announced that the company's Epic Plus and Epic Plus Supra Stented Tissue Valves have received FDA approval, expanding treatment options for patients with aortic or mitral valve dysfunction.

In January 2020, Medtronic Inc. announced that its Cobalt and Crome cardiac resynchronization therapy-defibrillators (CRT-D) and implanted cardioverter-defibrillators (ICD) received EU CE Mark certification, permitting their entry to the continent.

In June 2019, Biotronik announced the release of a new model of its well-known injectable heart monitor, BIOMONITOR. While being significantly smaller than the BIOMONITOR 2, the BIOMONITOR III provides a substantially crisper signal quality.

Key Questions Answered in This Report:

• How has the global cardiac prosthetic devices market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global cardiac prosthetic devices market?
• What is the impact of each driver, restraint, and opportunity on the global cardiac prosthetic devices market?
• What are the key regional markets?
• Which countries represent the most attractive cardiac prosthetic devices market?
• What is the breakup of the market based on the product type?
• Which is the most attractive product type in the cardiac prosthetic devices market?
• What is the breakup of the market based on the end-user?
• Which is the most attractive end-user in the cardiac prosthetic devices market?
• What is the competitive structure of the global cardiac prosthetic devices market?
• Who are the key players/companies in the global cardiac prosthetic devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Cardiac Prosthetic Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Valves
  • 6.1.1 Market Trends
  • 6.1.2 Major Types
    • 6.1.2.1 Mechanical Valve
    • 6.1.2.2 Tissue Valve
    • 6.1.2.3 Stented Tissue Valve
    • 6.1.2.4 Stentless Tissue Valve
    • 6.1.2.5 Transcatheter Valve
  • 6.1.3 Market Forecast
• 6.2 Pacemakers
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Implantable Pacemakers
  • 6.3.1 Market Trends
  • 6.3.2 Major Types
    • 6.3.2.1 Single-Chamber Battery Pacemaker
    • 6.3.2.2 Dual-Chamber Battery Pacemaker
    • 6.3.2.3 Triple-Chamber Battery Pacemaker
  • 6.3.3 Market Forecast
• 6.4 External Pacemakers
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Others
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by End-User

• 7.1 Hospitals, Clinics and Cardiac Centers
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Ambulatory Surgical Centers
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Abbott Laboratories
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 Biotronik
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 Boston Scientific Corporation
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 Edwards Lifesciences Corporation
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
  • 13.3.5 Lepu Medical Technology Co. Ltd.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
  • 13.3.6 Medtronic Inc.
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
  • 13.3.7 Meril Life Sciences Pvt. Ltd.
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
  • 13.3.8 Siemens Healthcare GmbH
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
  • 13.3.9 Sorin Group
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
  • 13.3.10 St. Jude Medical Inc.
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio